Literature DB >> 22517919

Identification of hamster inducible nitric oxide synthase (iNOS) promoter sequences that influence basal and inducible iNOS expression.

Omar A Saldarriaga1, Bruno L Travi, Goutam Ghosh Choudhury, Peter C Melby.   

Abstract

IFN-γ/LPS-activated hamster (Mesocricetus auratus) macrophages express significantly less iNOS (NOS2) than activated mouse macrophages, which contributes to the hamster's susceptibility to intracellular pathogens. We determined a mechanism responsible for differences in iNOS promoter activity in hamsters and mice. The HtPP (1.2 kb) showed low basal and inducible promoter activity when compared with the mouse, and sequences within a 100-bp region (-233 to -133) of the mouse and hamster promoters influenced this activity. Moreover, within this 100 bp, we identified a smaller region (44 bp) in the mouse promoter, which recovered basal promoter activity when swapped into the hamster promoter. The mouse homolog (100-bp region) contained a cis-element for NF-IL-6 (-153/-142), which was absent in the hamster counterpart. EMSA and supershift assays revealed that the hamster sequence did not support the binding of NF-IL-6. Introduction of a functional NF-IL-6 binding sequence into the hamster promoter or its alteration in the mouse promoter revealed the critical importance of this transcription factor for full iNOS promoter activity. Furthermore, the binding of NF-IL-6 to the iNOS promoter (-153/-142) in vivo was increased in mouse cells but was reduced in hamster cells after IFN-γ/LPS stimulation. Differences in the activity of the iNOS promoters were evident in mouse and hamster cells, so they were not merely a result of species-specific differences in transcription factors. Thus, we have identified unique DNA sequences and a critical transcription factor, NF-IL-6, which contribute to the overall basal and inducible expression of hamster iNOS.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22517919      PMCID: PMC3382312          DOI: 10.1189/jlb.1010568

Source DB:  PubMed          Journal:  J Leukoc Biol        ISSN: 0741-5400            Impact factor:   4.962


  45 in total

Review 1.  NO as a signaling molecule: effects on kinases.

Authors:  H Schindler; C Bogdan
Journal:  Int Immunopharmacol       Date:  2001-08       Impact factor: 4.932

2.  CCAAT/enhancer-binding protein (C/EBP) beta is acetylated at multiple lysines: acetylation of C/EBPbeta at lysine 39 modulates its ability to activate transcription.

Authors:  Teresa I Ceseña; Jean-Rene Cardinaux; Roland Kwok; Jessica Schwartz
Journal:  J Biol Chem       Date:  2006-11-15       Impact factor: 5.157

3.  Reduced nitric oxide synthase 2 (NOS2) promoter activity in the Syrian hamster renders the animal functionally deficient in NOS2 activity and unable to control an intracellular pathogen.

Authors:  Luis E Perez; Bysani Chandrasekar; Omar A Saldarriaga; Weiguo Zhao; Lourdes T Arteaga; Bruno L Travi; Peter C Melby
Journal:  J Immunol       Date:  2006-05-01       Impact factor: 5.422

4.  The hamster as a model of human visceral leishmaniasis: progressive disease and impaired generation of nitric oxide in the face of a prominent Th1-like cytokine response.

Authors:  P C Melby; B Chandrasekar; W Zhao; J E Coe
Journal:  J Immunol       Date:  2001-02-01       Impact factor: 5.422

Review 5.  Reactive oxygen and nitrogen intermediates in the relationship between mammalian hosts and microbial pathogens.

Authors:  C Nathan; M U Shiloh
Journal:  Proc Natl Acad Sci U S A       Date:  2000-08-01       Impact factor: 11.205

6.  Biological activity of hamster interferon-gamma is modulated by the carboxyl-terminal tail.

Authors:  Weiguo Zhao; Anais Z Valencia; Peter C Melby
Journal:  Cytokine       Date:  2006-07-13       Impact factor: 3.861

7.  Formation of nitric oxide by rat and hamster alveolar macrophages: an interstrain and interspecies comparison.

Authors:  N K Jesch; M Dörger; K Messmer; F Krombach
Journal:  Toxicol Lett       Date:  1998-08       Impact factor: 4.372

8.  O-linked N-acetylglucosamine modification on CCAAT enhancer-binding protein beta: role during adipocyte differentiation.

Authors:  Xi Li; Henrik Molina; Haiyan Huang; You-You Zhang; Mei Liu; Shu-Wen Qian; Chad Slawson; Wagner B Dias; Akhilesh Pandey; Gerald W Hart; M Daniel Lane; Qi-Qun Tang
Journal:  J Biol Chem       Date:  2009-05-28       Impact factor: 5.157

9.  Validation of assays to monitor immune responses in the Syrian golden hamster (Mesocricetus auratus).

Authors:  Marko Zivcec; David Safronetz; Elaine Haddock; Heinz Feldmann; Hideki Ebihara
Journal:  J Immunol Methods       Date:  2011-02-17       Impact factor: 2.303

10.  Progressive visceral leishmaniasis is driven by dominant parasite-induced STAT6 activation and STAT6-dependent host arginase 1 expression.

Authors:  E Yaneth Osorio; Weiguo Zhao; Claudia Espitia; Omar Saldarriaga; Leo Hawel; Craig V Byus; Bruno L Travi; Peter C Melby
Journal:  PLoS Pathog       Date:  2012-01-19       Impact factor: 6.823

View more
  7 in total

Review 1.  Immunopathogenesis of non-healing American cutaneous leishmaniasis and progressive visceral leishmaniasis.

Authors:  Lynn Soong; Calvin A Henard; Peter C Melby
Journal:  Semin Immunopathol       Date:  2012-10-11       Impact factor: 9.623

2.  Antileishmanial Activity of Disulfiram and Thiuram Disulfide Analogs in an Ex Vivo Model System Is Selectively Enhanced by the Addition of Divalent Metal Ions.

Authors:  Alex G Peniche; Adam R Renslo; Peter C Melby; Bruno L Travi
Journal:  Antimicrob Agents Chemother       Date:  2015-08-03       Impact factor: 5.191

3.  Transcriptional profiling of the spleen in progressive visceral leishmaniasis reveals mixed expression of type 1 and type 2 cytokine-responsive genes.

Authors:  Claudia M Espitia; Omar A Saldarriaga; Bruno L Travi; E Yaneth Osorio; Alvaro Hernandez; Mark Band; Mandakini J Patel; Audrie A Medina; Michael Cappello; Andrew Pekosz; Peter C Melby
Journal:  BMC Immunol       Date:  2014-11-26       Impact factor: 3.615

4.  Transcriptional Profiling in Experimental Visceral Leishmaniasis Reveals a Broad Splenic Inflammatory Environment that Conditions Macrophages toward a Disease-Promoting Phenotype.

Authors:  Fanping Kong; Omar A Saldarriaga; Heidi Spratt; E Yaneth Osorio; Bruno L Travi; Bruce A Luxon; Peter C Melby
Journal:  PLoS Pathog       Date:  2017-01-31       Impact factor: 6.823

5.  Species-Specific Transcriptional Regulation of Genes Involved in Nitric Oxide Production and Arginine Metabolism in Macrophages.

Authors:  Rachel Young; Stephen J Bush; Lucas Lefevre; Mary E B McCulloch; Zofia M Lisowski; Charity Muriuki; Lindsey A Waddell; Kristin A Sauter; Clare Pridans; Emily L Clark; David A Hume
Journal:  Immunohorizons       Date:  2018-01-01

Review 6.  Animal models for highly pathogenic emerging viruses.

Authors:  David Safronetz; Thomas W Geisbert; Heinz Feldmann
Journal:  Curr Opin Virol       Date:  2013-02-09       Impact factor: 7.090

7.  Immucillins ImmA and ImmH Are Effective and Non-toxic in the Treatment of Experimental Visceral Leishmaniasis.

Authors:  Elisangela Oliveira Freitas; Dirlei Nico; Marcus Vinícius Alves-Silva; Alexandre Morrot; Keith Clinch; Gary B Evans; Peter C Tyler; Vern L Schramm; Clarisa B Palatnik-de-Sousa
Journal:  PLoS Negl Trop Dis       Date:  2015-12-23
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.